Envista

NVST

Market cap $4.79B

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?

NVST shares jump 22% after Q4 EPS and revenue beat, with profits up 58% and double-digit segment growth despite gross margin pressure.

SANM, NVST and WDC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on February 12, 2026.

Broker upgrades make J, NVST and TPR top picks amid an AI-driven sell-off as markets demand clearer AI monetization and disciplined spending.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.